The Tipping Point. Brita Roy, MD MPH MS F. Stanford Massie Jr., MD
|
|
- Gabriel Gary Davidson
- 5 years ago
- Views:
Transcription
1 The Tipping Point Brita Roy, MD MPH MS F. Stanford Massie Jr., MD
2 Learning Objectives 1. To recognize an important cause of fever, somnolence, and rigidity. 2. To appreciate the dangers of polypharmacy.
3 History of Present Illness 39-year-old white woman Chief complaint: Fever, somnolence Initiated methadone treatment for chronic pelvic pain TMP/SMX Urinary tract infection symptoms Anxious Increased somnolence and confusion Fever, tremors, and altered mental status 4-days prior 3-days prior 2-days prior 1-day prior Emergency Department
4 Past Medical History Chronic pelvic pain Hypothyroidism Diabetes mellitus Anxiety Depression Migraine headaches
5 Medications Levothyroxine Metformin Pravastatin Zonisamide Citalopram Buspirone Quetiapine Amitryptiline Meclizine Promethazine Prochlorperazine Gabapentin TMP/SMX Methadone
6 Physical Exam T F HR122/min R 27/min BP 92/63mmHg Gen: Somnolent, profusely diaphoretic, speech unintelligible HEENT: Pupils dilated (reactive), no papilledema CV: Tachycardic, no murmurs GI: Soft, non-distended, hypoactive bowel sounds Neuro: Rigid in all extremities, spontaneous tremors, inducible clonus, hyperreflexic
7 Testing Laboratory: < LFTs: normal UDS: + methadone > < N, 6L, 6M, 1B CPK: 567 IU/L U/A: + LE, + Nitrite CT Head: normal
8 Assessment 39 year-old woman with: Fever and SIRS Somnolence Recent symptoms of urinary tract infection Urosepsis Rigidity Clonus Recent initiation of methadone
9 Differential Diagnosis Fever, somnolence, and rigidity Infection (SIRS/sepsis) Encephalitis Non-convulsive seizures Malignant hyperthermia Neuroleptic malignant syndrome Acute baclofen withdrawal Anticholinergic toxicity Serotonin syndrome
10 Serotonin Syndrome Hunter Serotonin Toxicity Criteria: 1 of the following after exposure to serotonergic agent Spontaneous clonus Inducible clonus with agitation or diaphoresis Ocular clonus with agitation or diaphoresis Tremor and hyperreflexia Hypertonia, T >100.4 F, ocular or inducible clonus Sensitivity 84%, specificity 97% QJM. 2003;96(9):635-42
11 Serotonin Syndrome Hunter Serotonin Toxicity Criteria: 1 of the following after exposure to serotonergic agent Spontaneous clonus Inducible clonus with agitation or diaphoresis Ocular clonus with agitation or diaphoresis Tremor and hyperreflexia Hypertonia, T >100.4 F, ocular or inducible clonus Sensitivity 84%, specificity 97% QJM. 2003;96(9):635-42
12 Serotonin Syndrome Other findings Elevated white blood cell count Elevated creatine phosphokinase Elevated transaminases Metabolic acidosis Serum serotonin levels do not correlate with clinical findings
13 Serotonin Syndrome Other findings Elevated white blood cell count Elevated creatine phosphokinase Elevated transaminases Metabolic acidosis Serum serotonin levels do not correlate with clinical findings
14
15 Cause of Serotonin Syndrome Drugs acting on receptor Amphetamines Antipsychotics Antiemetics Anti-migraines Linezolid Increase 5HT availability Monoamine oxidase inhibitors (MAOIs) Selective serotonin reuptake inhibitors (SSRI) Synthetic opioids Methadone Tramadol Dextromethorphan
16 Medications Levothyroxine Metformin Pravastatin Zonisamide Citalopram Buspirone Quetiapine Amitryptiline Meclizine Promethazine Prochlorperazine Gabapentin
17 Medications Levothyroxine Metformin Pravastatin Zonisamide Citalopram Buspirone Quetiapine Amitryptiline Meclizine Promethazine Prochlorperazine Gabapentin
18
19 The Tipping Point Prochlorperazine Promethazine Zonisamide Amytriptiline Quetiapine Citalopram Buspirone
20 The Tipping Point Methadone Prochlorperazine Promethazine Zonisamide Amytriptiline Quetiapine Citalopram Buspirone
21 The Tipping Point Methadone Prochlorperazine Promethazine Zonisamide Amytriptiline Quetiapine Citalopram Buspirone
22 Treatment If untreated, serotonin syndrome rapidly progresses to multiorgan failure High mortality rate 1. Removal of all offending agents 2. Supportive care 3. Benzodiazepines 4. Cyproheptadine - serotonin 2A antagonist
23 Our Patient Intravenous fluids Empiric antibiotics Held methadone, promethazine, prochlorperazine, SSRI, buspirone, zonisamide, quetiapine, and amytriptiline Benzodiazepines
24 Prevention AVOID POLYPHARMACY!
25 Conclusions Recognize serotonin syndrome in patients presenting with fever, somnolence and rigidity. Synthetic opioids can contribute to serotonin syndrome. Polypharmacy can be lethal.
26 THANK YOU! QUESTIONS?
Section I: EPS and NMS Nauman Ashraf, M.D. Section II: Serotonin Syndrome and Seizure Disorders Constanza Martinez, M.D.
Pharmacologic Induced Movement & Neurologic Disorders Section I: EPS and NMS Nauman Ashraf, M.D. Section II: Serotonin Syndrome and Seizure Disorders Constanza Martinez, M.D. Pharmacologic Induced Movement
More informationRestlessness, muscle twitches, and diarrhea.
http://www.medicine-on-line.com Restlessness, twitches & diarrhea: 1/7 Case 062: Restlessness, muscle twitches, and diarrhea. Authors: * Jason Ko MB BS, MRCP # David C Chung MD, FRCPC Affiliations: *Tuen
More information3/27/2013. Objectives. Psychopharmacology at the End of Life Nicole Thurston, MD
Psychopharmacology at the End of Life Nicole Thurston, MD Psychiatrist Mountain States Tumor Institute Objectives Describe 2 common psychiatric symptoms that can present at or near end of life. Review
More informationSerotonin Syndrome in the Intensive Care Unit: Clinical Presentations and Precipitating Medications
Neurocrit Care (2014) 21:108 113 DOI 10.1007/s12028-013-9914-2 ORIGINAL ARTICLE Serotonin Syndrome in the Intensive Care Unit: Clinical Presentations and Precipitating Medications Swetha Pedavally Jennifer
More informationDepression & Suicide 7/11/2017 DISCLOSURES. DSM 5 Depressive Disorders. Objectives
DISCLOSURES Depression & Suicide July 19, 2017 GenaLynne C. Mooneyham, MD, MS Pediatrics/Psychiatry/Child & Adolescent Psychiatry No financial disclosures There may be discussion of off label medication
More informationPRESCRIBING PRACTICE IN DELIRIUM. John Warburton Critical Care Pharmacist
PRESCRIBING PRACTICE IN DELIRIUM John Warburton Critical Care Pharmacist Learning outcomes Modifiable medication risk factors for delirium An appreciation of contributing factors modifiable with medicines
More informationToxic Fever. Dr. Mohammed Alhelail, MBBS, SBEM, ArBEM, FACMT
Toxic Fever Dr. Mohammed Alhelail, MBBS, SBEM, ArBEM, FACMT Vice President, Saudi Society of Emergency Medicine Consultant, Emergency Medicine & Medical Toxicology King Abdulaziz Medical City, Riyadh Saudi
More informationDancing with Death: MDMA, PMMA and other 4 letter words
Dancing with Death: MDMA, PMMA and other 4 letter words Mark Yarema, MD FRCPC Poison and Drug Information Service Alberta Health Services AARC Community Intervention Series March 15, 2016 Objectives At
More informationAnti-Depressant Medications
Anti-Depressant Medications A Introduction: This topic may be a little bit underestimated here in Jordan, while in western countries it has more significance. The function of anti-depressants is to change
More informationDANA BARTLETT, RN, MA, MSN
SEROTONIN SYNDROME DANA BARTLETT, RN, MA, MSN Dana Bartlett is a professional nurse and author. His clinical experience includes 16 years of ICU and ER experience and over 20 years of as a poison control
More information(levomilnacipran) extended-release capsules
MEDICATION GUIDE FETZIMA (fet-zee-muh) (levomilnacipran) extended-release capsules Read this Medication Guide before you start taking FETZIMA and each time you get a refill. There may be new information.
More informationCOALINGA STATE HOSPITAL. Effective Date: August 31, 2006
COALINGA STATE HOSPITAL NURSING POLICY AND PROCEDURE MANUAL SECTION Emergency Procedures POLICY NUMBER: 717 Effective Date: August 31, 2006 SUBJECT: NEUROLEPTIC MALIGNANT SYNDROME 1. PURPOSE: To provide
More informationDoctor Discussion Guide
Doctor Discussion Guide What should I tell my doctor? Talking to your doctor about depression doesn t have to be as hard as you may think. These simple tips can help you gather information and prepare
More informationLinezolid and Serotonergic Drug Interactions: A Retrospective Survey
MAJOR ARTICLE Linezolid and Serotonergic Drug Interactions: A Retrospective Survey Jeremy J. Taylor, 2,a John W. Wilson, 1 and Lynn L. Estes 2 1 Division of Infectious Diseases and 2 Department of Pharmacy,
More informationmovement disorders for psychiatrists
Movement disorders for psychiatrists Nandakumar Narayanan Assistant Professor, Neurology University of Iowa Thanks to Dr. Rodnitkzy Funding for my lab National Institutes of Health Carver Medical Trust
More informationToxi-what? Toxidrome. Portmanteau of toxic syndrome
Toxidromes Toxi-what? Toxidrome Portmanteau of toxic syndrome It is a constellation of commonly seen features and exam findings that are typical for certain types of poisonings Toxidrome History Symptoms
More informationAntidepressants: Prof. Riyadh Al_Azzawi F.R.C.Psych
Antidepressants: Prof. Riyadh Al_Azzawi F.R.C.Psych A. Heterocyclic antidepressants: (tricyclic and tetracyclic ), e.g.amitryptaline,imipramine. B. Monoamine oxidase inhibitors(m.a.o.i), e.g.phenelzine.
More informationChapter 161 Antipsychotics
Chapter 161 Antipsychotics Episode Overview Extrapyramidal syndromes are a common complication of antipsychotic medications. First line treatment is benztropine or diphenhydramine. Lorazepam is used in
More information1.Suicidal thoughts or actions:
Medication Guide FLUOXETINE (Floa-OX-e-teen) TABLETS, USP Read the Medication Guide that comes with fluoxetine tablets before you start taking it and each time you get a refill. There may be new information.
More informationIntroduction to Drug Treatment
Introduction to Drug Treatment LPT Gondar Mental Health Group www.le.ac.uk Introduction to Psychiatric Drugs Drugs and Neurotransmitters 5 Classes of Psychotropic medications Mechanism of action Clinical
More informationROS: all remaining ROS negative
Case # 1 CC: altered mental status HPI: 13 yo male presents with altered metal status. Child`s mother was called by the school nurse to pick her child up from school today due to child`s unusual behavior.
More informationVenlafaxine hydrochloride extended-release and other antidepressant medicines may cause serious side effects, including:
Medication Guide VENLAFAXINE XR (venlafaxine hydrochloride) (Extended-Release Capsules) Read the Medication Guide that comes with venlafaxine hydrochloride extended-release before you start taking it and
More informationYa Give Me Fever: Hot and Bothered
Ya Give Me Fever: Hot and Bothered Steve Alan Hyman, MD MM Professor of Anesthesiology Vanderbilt University School of Medicine Introduction Request for a discussion of Serotonin Syndrome SS has many symptoms,
More informationPrescribing and Administration of Analgesia within Maternity
Prescribing and Administration of Analgesia within Maternity CONTENTS Introduction and Who The Guideline Applies To... 2 UHL Paracetamol Prescribing Guideline... 2 Oral dosing... 2 Intravenous dosing...
More informationSANDOMIGRAN (pizotifen malate)
SANDOMIGRAN (pizotifen malate) S N CH 3 Pizotifen. COOH CH OH CH 2 COOH MALATE DESCRIPTION Pizotifen is a cycloheptathiophene derivative structurally related to cyproheptadine and the tricyclic antidepressants.
More informationMedication Guide SARAFEM (SAIR-a-fem) (fluoxetine hydrochloride) Tablets
Medication Guide SARAFEM (SAIR-a-fem) (fluoxetine hydrochloride) Tablets Read the Medication Guide that comes with SARAFEM before you start taking it and each time you get a refill. There may be new information.
More informationNeither activated charcoal nor whole bowel irrigation (WBI) is indicated in the routine management of acute or chronic lithium toxicity.
CRACKCast E160 Lithium Key concepts; The clinical pattern of acute and chronic toxicity is different. Gastrointestinal symptoms occur early and neurological toxicity manifest late in acute toxicity. Neurological
More informationMedication Guide Fluoxetine Oral Solution USP What is the most important information I should know about fluoxetine oral solution?
Medication Guide Fluoxetine Oral Solution USP Read the Medication Guide that comes with fluoxetine before you start taking it and each time you get a refill. There may be new information. This Medication
More informationCommonly encountered medications and their side effects - what the generalist needs to know
Commonly encountered medications and their side effects - what the generalist needs to know Jeremy Cosgrove Consultant Neurologist Leeds Teaching Hospitals NHS Trust Outline: Parkinson s medications and
More informationToxicology and Management of SSRI Overdose
Toxicology and Management of SSRI Overdose Casey O Connell, PharmD, RN PGY1 Pharmacy Practice Resident October 9, 2018 OConnell.Casey@mayo.edu 2018 MFMER slide-1 All things are poison, and nothing is without
More informationSEROTONIN SYNDROME IN CLOZAPINE WITHDRAWAL. Ashley Pirozzi, MD PGY2, Psychiatry Dept California Pacific Medical Center
SEROTONIN SYNDROME IN CLOZAPINE WITHDRAWAL Ashley Pirozzi, MD PGY2, Psychiatry Dept California Pacific Medical Center PRESENTATION OUTLINE Case Presentation Clozapine Clozapine withdrawal Symptoms Possibility
More informationSerotonin Syndrome. Learning Objectives. Serotonin syndrome is. What is serotonin? Demographics and Incidence. What does serotonin do?
Serotonin Syndrome Ma# Neukirch Pharm.D., BCPS Iowa Physician Assistant Society Fall CME 2016 Coralville, IA Learning Objectives Discuss the pathophysiology of serotonin syndrome (SS) Discuss the medicaions
More informationMedication Guide. Escitalopram (ES-sye-TAL-oh-pram) Tablets USP
17.2 FDA-Approved Medication Guide Medication Guide Escitalopram (ES-sye-TAL-oh-pram) Tablets USP Read the Medication Guide that comes with escitalopram tablets before you start taking it and each time
More information(safinamide) tablets
FOR PARKINSON S DISEASE (PD) GET TO KNOW XADAGO can increase your daily on time without troublesome dyskinesia (uncontrolled movement) Please see the complete on pages 14-15 and For Parkinson s disease
More informationDEMENTIA and BPSD in PARKINSON'S DISEASE. DR. T. JOHNSON. NOVEMBER 2017.
DEMENTIA and BPSD in PARKINSON'S DISEASE. DR. T. JOHNSON. NOVEMBER 2017. Introduction. Parkinson's disease (PD) has been considered largely as a motor disorder. It has been increasingly recognized that
More information1995 Called - They Want Your Boring Lectures Back Bringing Tech into the Classroom
1995 Called - They Want Your Boring Lectures Back Bringing Tech into the Classroom Corey Heitz, MD Department of Emergency Medicine Who is apprehensive about using newer teaching technologies? Why? Sage
More informationMedication Guide Escitalopram Tablets (ES-sye-TAL-oh-pram)
Medication Guide Escitalopram Tablets (ES-sye-TAL-oh-pram) Read the Medication Guide that comes with escitalopram tablets before you start taking it and each time you get a refill. There may be new information.
More informationCITALOPRAM Product Monograph Page 46 of 50
PART III: CONSUMER INFORMATION Pr CITALOPRAM Citalopram Tablets, BP This leaflet is part III of a three-part Product Monograph published when CITALOPRAM was approved for sale in Canada and is designed
More informationPoisoning: from paracetamol to legal highs.
Poisoning: from paracetamol to legal highs. or Something old, something new, something borrowed, something blue. Nick Bateman University of Edinburgh Question 1 Which of the following agents was associated
More informationNeuro Basics SLO Practice (online) Page 1 of 5
Neuro Basics SLO Practice (online) Page 1 of 5 1) Biogenic amines include ACh, NE, EPI and? a) Melatonin b) Dopamine c) Serotonin d) Histamine e) All of the neurotransmitters listed are biogenic amines.
More informationThis article appeared in a journal published by Elsevier. The attached copy is furnished to the author for internal non-commercial research and
This article appeared in a journal published by Elsevier. The attached copy is furnished to the author for internal non-commercial research and education use, including for instruction at the authors institution
More informationDelayed Recovery from General Anaesthesia: A Post-operative Diagnostic Dilemma and Implications of ICU Management of Serotonin Toxicity.
The Journal of Critical Care Medicine 2015;1(4):174-178 CASE REPT Delayed Recovery from General Anaesthesia: A Post-operative Diagnostic Dilemma and Implications of ICU Management of Serotonin Toxicity.
More information90 dosage units per 90 days OR. Extended-release Formulations Ultram ER 90 dosage units per 90 days OR
Pre - PA Allowance 12 years of age or older Quantity Immediate-release Formulation Ultracet 720 dosage units per 90 days OR Ultram 720 dosage units per 90 days Extended-release Formulations Ultram ER 90
More informationAnxiety Pharmacology UNIVERSITY OF HAWAI I HILO PRE -NURSING PROGRAM
Anxiety Pharmacology UNIVERSITY OF HAWAI I HILO PRE NURSING PROGRAM NURS 203 GENERAL PHARMACOLOGY DANITA NARCISO PHARM D Learning Objectives Understand the normal processing of fear vs fear processing
More informationAffective or Mood Disorders. Dr. Alia Shatanawi March 12, 2018
Affective or Mood Disorders Dr. Alia Shatanawi March 12, 2018 Affective or Mood Disorders Reactive Depression. Secondary: Medical Neurological Drugs Major (Endogenous) Depression = Unipolar: Depressed
More informationVA/DoD Clinical Practice Guideline for Management of Post Traumatic Stress. Core Module
VA/DoD Clinical Practice Guideline for Management of Post Traumatic Stress Core Module Module A Acute Stress Continue Treatment for ASD Treatment for ACUTE Stress Disorder Module B PTSD Continue Treatment
More informationManaging Medical Complications of Brain Injury. Katie Turpin, NP-C
Managing Medical Complications of Brain Injury Katie Turpin, NP-C Objectives: 1. Describe the role of the medical team in a setting focused on therapy/rehabilitation. 2. Identify common disabilities or
More informationI m Allergic to Everything
I m Allergic to Everything but. Prescription Medication Overdoses : There is more than Vicodin and Percocet Liza Halcomb, MD 10/23/15 Neuroleptics Haloperidol Risperidone Olanzapine Clozapine Ziprasadone
More informationPersistent Pulmonary Hypertension of the Newborn (PPHN) and newer antidepressants: Celexa Page 1 of 5
PART III: CONSUMER INFORMATION Pr Celexa Citalopram hydrobromide This leaflet is part III of a three-part Product Monograph published when Celexa was approved for sale in Canada and is designed specically
More informationLets start with a case
Heidi Hidi Combs MD Assistant Professor Harborview Medical Center At the end of this session you will be able to: Identify common psychiatric emergencies Manage agitated patients through behavioral and
More informationNoven Enters Co-Promotion Agreement with Shionogi for Brisdelle (Paroxetine) Capsules MIAMI and NEW YORK, January 13, 2014
Noven Enters Co-Promotion Agreement with Shionogi for Brisdelle (Paroxetine) Capsules Co-Promotion to Extend Physician Awareness of the First and Only FDA-Approved, Non-Hormonal Treatment for Moderate
More informationMentoring Session: Participant Cases
Handout for the Neuroscience Education Institute (NEI) online activity: Mentoring Session: Participant Cases The Case: 55-year-old patient with depression and anxiety The Question: What to do when antidepressants
More informationMedication Guide. What is the most important information I should know about SYMBYAX? SYMBYAX may cause serious side effects, including:
1 Medication Guide SYMBYAX (SIM-be-ax) (olanzapine and fluoxetine) Capsule Read the Medication Guide that comes with SYMBYAX before you start taking it and each time you get a refill. There may be new
More informationMedication Guide. Cymbalta. (duloxetine delayed-release capsules)
Medication Guide 1 Cymbalta [sim-ball-tah] (duloxetine delayed-release capsules) Read this Medication Guide before you start taking Cymbalta and each time you get a refill. There may be new information.
More informationStudy Guidelines for Quiz #1
Annex to Section J Page 1 Study Guidelines for Quiz #1 Theory and Principles of Psychopharmacology, Classifications and Neurotransmitters, Anxiolytics/Antianxiety/Minor Tranquilizers, Stimulants, Nursing
More informationThe presentations at NAMS reference Brisdelle as LDMP (low-dose mesylate salt of paroxetine), as it was referred to in clinical development.
Data on Brisdelle (Paroxetine) Capsules, the First and Only FDA-Approved Non- Hormonal Therapy for Moderate to Severe Vasomotor Symptoms Associated with Menopause, to be Presented at the 2013 Annual Meeting
More informationPsychiatric drugs. Team Leaders. Done by. Revised by: Yara & Basel. Khalid Aleedan & Aseel Badukhon. Ghaida Alsaeed. Monera Alayuni.
Psychiatric drugs Team Leaders Khalid Aleedan & Aseel Badukhon Done by Ghaida Alsaeed Essam Alshahrani Mohammed Alyousef Monera Alayuni Khalid Aleisa Revised by: Yara & Basel Ob e t 1 Not mentioned Notes
More informationUpdate to Product Monograph
Dear Healthcare Professional, July 2012 Please be informed that the AZILECT Product Monograph has been updated. The monograph format is in line with the new Product Monograph template Updated Contraindications
More informationPublic Case Detail. Causality possible Recovered
Case Number : 233493 M 18/9/27 Admitted to hospital 27/8/27 8/6/1968 2/9/27 Patient received haloperidol 2.5mg-5mg prn 3 doses. haloperidol 2/8/27 2 doses, 24/8/27 one dose, 25/8/27 one dose, 31/8/27 2.5mg,
More informationFirst and Only FDA-Approved, Non-Hormonal Treatment for Moderate to Severe Hot Flashes Now Available by Prescription in U.S.
First and Only FDA-Approved, Non-Hormonal Treatment for Moderate to Severe Hot Flashes Now Available by Prescription in U.S. Pharmacies The availability of Brisdelle (Paroxetine) capsules offers the millions
More informationThe Case of J.W. The Case of J.W. The Case of J.W. The Case of J.W. The Case of J.W. The Case of J.W. 11/23/2013
0925: Paramedic radio call 50 y/o male lives on sidewalk ; found down by passersby. GCS 4-6-4; Ox2. Doesn t know how he ended up on the ground. Laceration above left eye, repetitive questioning; exam otherwise
More informationDisclosure. Objectives: Technician. Objectives: Pharmacist. Diagnostic and Statistical Manual (DSM-V) The Face of Mental Illness 7/25/2015
49th Annual Meeting Psychiatry for the Non-Psychiatry Specialist Jacintha Cauffield, PharmD, BCPS, CDE Associate Professor of Pharmacy Practice Lloyd L. Gregory School of Pharmacy Palm Beach Atlantic University
More information1. NAME OF THE MEDICINAL PRODUCT
SURMONTIL TABLETS 25mg Data Sheet 1. NAME OF THE MEDICINAL PRODUCT SURMONTIL 25mg, scored tablet 2. ACTIVE INGREDIENT Trimipramine (as Maleate) EP 34.9mg equivalent to 25 mg trimipramine per tablet 3.
More informationThe heat is on (and on)
The heat is on (and on) Cornelis Kramers Internist clinical pharmacologist kees.kramers@radboudumc.nl Disclosure belangen spreker (potentiële) belangenverstrengeling Voor bijeenkomst mogelijk relevante
More informationGI Pharmacology -4 Irritable Bowel Syndrome and Antiemetics. Dr. Alia Shatanawi
GI Pharmacology -4 Irritable Bowel Syndrome and Antiemetics Dr. Alia Shatanawi 11-04-2018 Drugs used in Irritable Bowel Syndrome Idiopathic, chronic, relapsing disorder characterized by abdominal discomfort
More informationGUIDELINES FOR THE USE OF PSYCHOACTIVE MEDICATIONS IN INDIVIDUALS WITH CO-OCCURRING SUBSTANCE USE DISORDERS
City and County of San Francisco Mayor Gavin Newsom Department of Public Health Community Behavioral Health Services 1380 Howard Street 5 th Floor San Francisco, CA 94103 GUIDELINES FOR THE USE OF PSYCHOACTIVE
More informationRATIONALE FOR INCLUSION IN PA PROGRAM
RATIONALE FOR INCLUSION IN PA PROGRAM Background Tramadol is a centrally acting synthetic opioid analgesic used to treat moderate to moderately severe chronic pain in adults. Along from analgesia, tramadol
More informationCitalopram tablets and other antidepressant medicines may cause serious side effects, including:
Medication Guide Citalopram Tablets, USP (sye tal' oh pram) Read the Medication Guide that comes with citalopram tablets before you start taking them and each time you get a refill. There may be new information.
More informationReducing the Anxiety of Pediatric Anxiety Part 2: Treatment
Reducing the Anxiety of Pediatric Anxiety Part 2: Treatment Lisa Lloyd Giles, MD Medical Director, Behavioral Consultation, Crisis, and Community Services Primary Children s Hospital Associate Professor,
More informationMedication Guide REMERONSolTab (rĕm' - ĕ - rŏn - sŏl' tăb) (mirtazapine) Orally Disintegrating Tablets
Medication Guide REMERONSolTab (rĕm' - ĕ - rŏn - sŏl' tăb) (mirtazapine) Orally Disintegrating Tablets Read the Medication Guide that comes with REMERONSolTab before you start taking it and each time you
More information3. Severe allergic reactions: trouble breathing swelling of the face, tongue, eyes or mouth
MEDICATION GUIDE Sertraline Tablets, USP Read the Medication Guide that comes with Sertraline Tablets before you start taking them and each time you get a refill. There may be new information. This Medication
More information17.11 FDA-Approved Medication Guide Medication Guide LUVOX CR (LOO Vox CR) (Fluvoxamine Maleate) Extended-Release Capsules
17.11 FDA-Approved Medication Guide Medication Guide LUVOX CR (LOO Vox CR) (Fluvoxamine Maleate) Extended-Release Capsules Read the Medication Guide that comes with LUVOX CR Capsules before you start taking
More informationMEDICATION GUIDE Fluvoxamine Tablets (Flu VOX ah meen) What is the most important information I should know about fluvoxamine maleate tablets?
MEDICATION GUIDE Fluvoxamine Tablets (Flu VOX ah meen) Read the Medication Guide that comes with fluvoxamine maleate tablets before you start taking it and each time you get a refill. There may be new
More informationGuidelines MANAGEMENT OF MAJOR DEPRESSIVE DISORDER (MDD)
MANAGEMENT OF MAJOR DEPRESSIVE DISORDER (MDD) Guidelines CH Lim, B Baizury, on behalf of Development Group Clinical Practice Guidelines Management of Major Depressive Disorder A. Introduction Major depressive
More informationBeyond Standard Anticholinergics: The Use of Physostigmine for Reversal of Somnolence and Delirium in a Cohort of Overdose Patients
Beyond Standard Anticholinergics: The Use of Physostigmine for Reversal of Somnolence and Delirium in a Cohort of Overdose Patients Timothy J. Wiegand, MD Associate Clinical Professor of Emergency Medicine,
More information4/2/13 COMMON CLASSES OF MEDICATIONS. Child & Adolescent Behavioral Medicine & Medication Therapies. Behavioral Medicine & Medication Therapies
Child & Adolescent Behavioral Medicine & Medication Therapies Brian J Cowles, PharmD Associate Professor of Pharmacy Practice Albany College of Pharmacy & Health Sciences; Vermont Campus Behavioral Medicine
More informationClinical Guideline / Formulary Document Pharmacy Department Medicines Management Services
Clinical Guideline / Formulary Document Pharmacy Department Medicines Management Services DEPRESSION Pharmacological Treatment of Depression NICE guidelines suggest the following stepped care model also
More informationDementia Medications Acetylcholinesterase Inhibitors (AChEIs) and Glutamate (NMDA) Receptor Antagonist
Dementia Medications Acetylcholinesterase Inhibitors (AChEIs) and Glutamate (NMDA) Receptor Antagonist Medication Dosage Indication for Use Aricept (donepezil) Exelon (rivastigmine) 5mg 23mg* ODT 5mg Solution
More informationMEDICATION GUIDE FLUOXETINE TABLETS. What is the most important information I should know about fluoxetine?
MEDICATION GUIDE FLUOXETINE TABLETS Read the Medication Guide that comes with fluoxetine before you start taking it and each time you get a refill. There may be new information. This Medication Guide does
More informationESCITALOPRAM. THERAPEUTICS Brands Lexapro see index for additional brand names. Generic? Yes
ESCITALOPRAM THERAPEUTICS Brands Lexapro see index for additional brand names Generic? Yes Class SSRI (selective serotonin reuptake inhibitor); often classified as an antidepressant, but it is not just
More informationDsuvia (sufentanil) NEW PRODUCT SLIDESHOW
Dsuvia (sufentanil) NEW PRODUCT SLIDESHOW Introduction Brand name: Dsuvia Generic name: Sufentanil Pharmacological class: Opioid agonist Strength and Formulation: 30mcg; sublingual tabs (housed in a disposable,
More informationKeep all follow-up visits with your healthcare provider and call between visits if you are worried about symptoms.
MEDICATION GUIDE FLUVOXAMINE MALEATE TABLETS, USP (floo vox a meen mal ee ate) 25 mg, 50 mg and 100 mg Read the Medication Guide that comes with fluvoxamine maleate tablets before you start taking it and
More information17.8 Alcohol As with other psychotropic medications, patients should be advised to avoid alcohol while taking LUVOX CR Capsules.
17.6 Pregnancy Patients should be advised to notify their physicians if they become pregnant or intend to become pregnant during therapy with LUVOX CR Capsules (see USE IN SPECIFIC POPULATIONS [8.1]).
More informationIMPORTANT: PLEASE READ
PART III: CONSUMER INFORMATION Pr NAT-CITALOPRAM Citalopram tablets, USP This leaflet is Part III of a three-part "Product Monograph" published when NAT-Citalopram was approved for sale in Canada and is
More informationAnnex C. (variation to nationally authorised medicinal products)
Annex C (variation to nationally authorised medicinal products) Annex I Scientific conclusions and grounds for variation to the terms of the marketing authorisations Scientific conclusions Taking into
More informationWEIGHT LOSS/MANAGEMENT IS IT JUST ANOTHER PIPE DREAM?
WEIGHT LOSS/MANAGEMENT IS IT JUST ANOTHER PIPE DREAM? THE OBESITY MEDICINE ASSOCIATION S DEFINITION OF OBESITY Obesity is defined as a chronic, relapsing, multi-factorial, neurobehavioral disease, wherein
More informationMore information about Cymbalta is available in the current edition of MPR.
www.empr.com Clinical ALERT Dear Healthcare Professional, At MPR we strive to bring you important drug information in a timely fashion. In keeping with this goal, we are pleased to bring you this CLINICAL
More informationMEDICATION GUIDE PARNATE
MEDICATION GUIDE PARNATE (PAR-nate) (tranylcypromine) tablets What is the most important information I should know about PARNATE? PARNATE can cause serious side effects including: Increase in suicidal
More informationEU Risk Management Plan
6.2 Elements for Public Summary - Abilify 6.2.1 Overview of Disease Epidemiology Bipolar I Disorder Reported prevalence rates for bipolar I disorder differ due to local variations in psychiatric practice,
More informationEvaluation and Management of Children With Acute Mental
CLINICAL REPORT Guidance for the Clinician in Rendering Pediatric Care Evaluation and Management of Children With Acute Mental Health or Behavioral Problems. Part II: Recognition of Clinically Challenging
More information1/31/2009. Paroxysmal, uncontrolled electrical discharge of neurons in brain interrupting normal function
Paroxysmal, uncontrolled electrical discharge of neurons in brain interrupting normal function In epilepsy abnormal neurons undergo spontaneous firing Cause of abnormal firing is unclear Firing spreads
More informationKiller Drug Interactions. Karen Curzio Rodeghiero, PharmD, BCPS Clinical Pharmacist, Emergency Medicine Piedmont Athens Regional
Killer Drug Interactions Karen Curzio Rodeghiero, PharmD, BCPS Clinical Pharmacist, Emergency Medicine Piedmont Athens Regional Disclosure I have no financial interests or relationships to disclose Primum
More informationPlease review the following slides prior to class. Information from these slides will be used to answer patient cases. Come prepared!
Please review the following slides prior to class Information from these slides will be used to answer patient cases. Come prepared! Alcohol and Opiate Dependence Reference Slides Substances of Abuse A
More informationVI.2 Elements for a public summary. VI.2.1 Overview of disease epidemiology
VI.2 Elements for a public summary VI.2.1 Overview of disease epidemiology Incidence and prevalence of target indication Schizophrenia is a mental disorder characterized by a breakdown of thought processes
More informationTreating Depression in Adults
Treating Depression in Adults By Deborah Christensen, Ph.D., M.S.C.P. Depressive Disorders represent a broad and heterogeneous group of commonly diagnosed psychological disorders. The DSM adequately describes
More informationMental illness A Broad Overview. Dr H Pathmanandam March 2017
Mental illness A Broad Overview Dr H Pathmanandam March 2017 Introduction Mental disorders are common in primary and secondary care Many are not recognised and not treated Some receive unnecessary or inappropriate
More information